Formulary Search Results for: sativex
10.2.2 Skeletal muscle relaxants - View Category
Total Formulary
DELTA -9-TETRAHYDROCANNABINOL AND CANNABIDIOL (SATIVEX) (Oromucosal Spray)
Restrictions:
Restricted to specialist use.
Prescribing Notes:
Patients commencing treatment should be reviewed via a formal assessment conducted by the specialist service at 4 weeks. Treatment should be discontinued at that point if a clinically significant improvement is not seen. Patients should also continue to be reviewed regularly thereafter to ensure continuing benefit.